India to Canada: Anastrozole Export Trade Route
India has recorded 43 verified shipments of Anastrozole exported to Canada, representing a combined trade value of $1.2M USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $26.8K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 25% of total export value with 8 shipments worth $283.2K USD. On the buying side, Accord Healthcare Inc. is the largest importer in Canada with $233.6K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, NATCO PHARMA LIMITED, INTAS PHARMACEUTICALS LIMITED — together control 70% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Canada Anastrozole corridor is one of India's established pharmaceutical export routes, with 43 shipments documented worth a combined $1.2M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 25% of all export value, reflecting the consolidated nature of India's anastrozole manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $26.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with anastrozole's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 17.4%, placing it at rank #3 among India's top anastrozole export destinations globally.
On the import side, key buyers of Indian anastrozole in Canada include Accord Healthcare Inc., MARCAN PHARMACEUTICALS INC, MARCAN PHARMACEUTICALS INC, and 17 others. Accord Healthcare Inc. is the single largest importer with 1 shipments valued at $233.6K USD.
